patients starting second line drug treatment who require faster correction of their anaemia than would be achieved by the modifying effect on the disease of such drugs.
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Both groups were similar with respect to age, sex, height, weight, smoking history, lung function, and history of pneumothorax (table) . There were no significant differences between the two groups in either the size or side of pneumothorax. No difference was reported in pain experienced while undergoing drainage, but those treated by intercostal drainage experienced significantly more pain during their hospital admission and spent an average of two days longer in hospital (table) .
In all 28 out of 35 aspirations were successful, although five patients required two aspirations. The remaining seven patients were subsequently treated by intercostal drainage. None of them had a recurrence or required pleurectomy within one year. The amount of air aspirated during the first aspiration was significantly different in successful and unsuccessful aspirations (successful 1-59 (SD 0 72) v unsuccessful 2-52 (0-91) 1; P<0 01). A logistic regression model found no significant associations with failed aspiration. In particular, there was no association with a history of pneumothorax or initial radiographic appearances. No significant differences were found in the recurrence rate at one year, but more patients who had intercostal drainage required pleurectomy than those patients who had had aspiration (P-0-02).
Comment
Simple aspiration is a simple and safe procedure and should be the initial treatment of choice for patients with normal lungs who present with a spontaneous pneumothorax, irrespective of its size. This study has shown that aspiration is less painful than intercostal drainage, leads to a shorter admission, and reduces the need for pleurectomy with no increase in recurrence rate at one year.
As a result of this study, and after consultation with over 150 British respiratory physicians and thoracic Characteristics Universal rather than selective screening of pregnant women for hepatitis B virus is increasingly being adopted, and this will expand the difficulties encountered in immunising infants at risk. Universal hepatitis B vaccination incorporated into the schedule of routine childhood immunisations would reduce the practical difficulties we identified with the current selective programme. At present, neither the second nor third dose of vaccine coincides with routine childhood immunisations in the United Kingdom. Different vaccination schedules (0, 2, and 6 months) resulted in a seroconversion rate of 99% at 1 year,2 and protective antibody responses were seen one month after administering immunoglobulin and vaccine at birth.3 This implies that the second dose of vaccine could be delayed. Selective immunoglobulin administration would be reserved for babies at high risk. The problem of inadequate maternal records resulting in failure to deliver this treatment could be minimised by using the neonatal pack.4
